Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • PhamAust AGM 2022
    • Company Research
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • PhamAust AGM 2022
    • Company Research
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

Top 20 Shareholders October 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAust05/10/2018

top_holder_-_detail_-_single_date September

Mr Neville Bassett AM Appointed to PharmAust Board

News & Announcements 2018By PharmAust02/10/2018

181002_Neville Bassett

PharmAust 2018 Annual Report

Financial Reports 2018, News & Announcements 2018By PharmAust01/10/2018

181001_Annual_Report

Corporate Governance

News & Announcements 2018By PharmAust01/10/2018

181001_Corporate_Governance

Top 20 Shareholders September 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAust24/09/2018

Top 20 Shareholders Report_ 25Sept2018

Olivia Newton-John Cancer Research Institute Update

News & Announcements 2018By PharmAust10/09/2018

180910_ONJCRI Update

Preliminary Final Statements to the ASX

Financial Reports 2018, News & Announcements 2018By PharmAust03/09/2018

180903_Preliminary Final Report

Hope on the horizon for chemo alternative

News & Announcements 2018By PharmAust17/08/2018

Hope on the horizon for chemo alternative

Top 20 Shareholders August 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAust17/08/2018

Top 20 Shareholders August 2018

Hope on the horizon for chemo alternative

Articles In The NewsBy PharmAust17/08/2018
←1
2345678910111213141516171819202122232425262728
…2930313233…
343536373839404142434445464748495051
52→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

Facebook
Facebook
fb-share-icon
Twitter
YouTube

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on Twitter PharmAust Retweeted
stockheadau Stockhead @stockheadau ·
21 Nov

Newly appointed CEO of clinical-stage biopharmaceutical development company PharmAust Dr Michael Thurn says the company is well-positioned to capitalise on the lucrative rare diseases market.
#ad #ASX @PharmAust

Reply on Twitter 1727114614402437408 Retweet on Twitter 1727114614402437408 3 Like on Twitter 1727114614402437408 6 Twitter 1727114614402437408
pharmaust PharmAust @pharmaust ·
22 Nov

Why this ASX biotech is primed to capitalise as big pharma flocks to the rare diseases market

Reply on Twitter 1727116385040716075 Retweet on Twitter 1727116385040716075 4 Like on Twitter 1727116385040716075 8 Twitter 1727116385040716075
pharmaust PharmAust @pharmaust ·
21 Nov

PharmAust has released a formal video of its recent non-deal #roadshow presentation.

🎥 https://vimeo.com/884693453/12f5b671d2

Reply on Twitter 1726832212392518124 Retweet on Twitter 1726832212392518124 1 Like on Twitter 1726832212392518124 4 Twitter 1726832212392518124
Load More

Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top